1. TEAD1 mediates the oncogenic activities of Hippo-YAP1 signaling in osteosarcoma.
- Author
-
Chai, Jiwei, Xu, Shijie, and Guo, Fengbo
- Subjects
- *
OSTEOSARCOMA , *GENE silencing , *APOPTOSIS , *ONCOGENES , *TRANSCRIPTION factors , *CELL proliferation , *THERAPEUTICS - Abstract
Hippo signaling pathway is an evolutionarily conserved developmental network that governs the downstream transcriptional co-activators, YAP and TAZ, which bind to and activate the output of TEADs that responsible for cell proliferation, apoptosis, and stem cell self renewal. Emerging evidence has shown the tumor suppressor properties of Hippo signaling. However, limited knowledge is available concerning the downstream transcription factors of Hippo pathway in osteosarcoma (OS). In this study, we demonstrated that TEAD1 was the major transcription factor of Hippo signaling pathway in OS. Genetic silencing of TEAD1 suppressed multiple malignant phenotypes of OS cells including cell proliferation, apoptosis resistance, and invasive potential. Mechanistically, we showed that TEAD1 largely exerted its transcriptional control of its functional targets, PTGS2 and CYR61. Collectively, this work identifies the YAP1/TEAD1 complex as the representative dysregulated profile of Hippo signaling in OS and provides proof-of-principle that targeting TEAD1 may be a therapeutic strategy of osteosarcoma. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF